Cases selected for the AskAnzal weekly PMCPA insight newsletter
A two-page Amias ad compared ARBs in heart failure and marked losartan as a black triangle drug. PMCPA…
UCB voluntarily admitted a paid advertorial in a Parkinsonβs Disease supplement distributed with The Times that named Keppra…
A Qutenza journal insert styled as a βconsensus statementβ and βadapted from NICEβ was ruled misleading: funding/organisation by…
Ex-employee alleged archived investor presentations made false/imbalanced claims about Seroquel and weight gain. Panel and Appeal Board ruled…
Pierre Fabre admitted multiple ABPI Code breaches after using and emailing uncertified cycle-meeting materials for Toviaz, including misleading…
A member of the public alleged MSD failed to disclose clinical trial results on time for Brinavess, Sycrest…
A health professional challenged AbbVieβs Humira ad claim βFast symptom relief from week 1 (CD) and week 2…
Martindaleβs Espranor launch materials (open website, detail aids, patient leaflet) were ruled to promote a POM to the…
A PCT complained a Novartis rep said Exforge was endorsed by the PCT. Evidence suggested a misunderstanding between…
PMCPA case AUTH/2967/8/17 (Consultant v Shire). Allegation: omission of prescribing and obligatory information. Outcome: no breach; matter found…
One real case. One key lesson. Every week β free.